Abstracts
Résumé
Depuis quelques années, la présence de substances pharmaceutiques a été observée dans les milieux aquatiques y compris dans l’eau potable. Les principales sources de dispersion de ces composés dans l’environnement sont les stations d’épuration des eaux usées (STEP). Une analyse de la littérature publiée sur le sujet est proposée. Ce sont les analgésiques/anti-inflammatoires, les hypocholestérolémiants, les cytostatiques et les bêta-bloquants qui présentent les concentrations les plus élevées en entrée de station d’épuration. Malgré des rendements d’élimination quelquefois très élevés, les concentrations de ces groupes de médicaments restent non négligeables dans les effluents de stations.
Les antibiotiques forment un des plus importants groupes de médicaments à cause de leur niveau de consommation, de leur fréquence de détection dans les milieux aquatiques et de leur action spécifique sur les bactéries, notamment celle potentiellement néfaste qu’ils peuvent avoir sur les bactéries mises en oeuvre dans les systèmes de traitement biologique des eaux résiduaires urbaines. Globalement, la charge en antibiotiques est faible dans les eaux usées urbaines mais elle est forte dans les effluents des hôpitaux. Les rendements d’élimination sont, quant à eux très variables, allant de 0 % pour le nitrothiazole à 95 % pour la tétracycline.
Mots clés:
- antibiotique,
- bactérie,
- élimination,
- résistance,
- traitement des eaux usées
Abstract
For several years, the occurrence of pharmaceutical substances in the aquatic environment, and even in drinking water, has been a source of concern. The main sources of dispersion of these substances are wastewater treatment plants (WWTP). An analysis of the available literature on this topic is proposed. Analgesic, anti-inflammatory, anti-cholesterol and cytostatic drugs as well as beta-blockers are the substances that can be found in the highest concentrations in plant influents. In spite of elimination yields that can be very high, their concentrations in plant effluents can remain non-negligible. Antibiotics are one of the most important drug classes, due to their large consumption, their prevalence in aquatic systems and their specific action on bacteria, especially on those used in urban wastewater treatment biosystems. Globally, antibiotic concentrations in urban wastewater are normally low but they can be high in hospital wastewater. Elimination yields are very variable, ranging from a low of 0% for nitrothiazole to 95% for tetracycline.
Keywords:
- antibiotic,
- bacteria,
- elimination,
- resistance,
- wastewater treatment
Appendices
Références bibliographiques
- AL-AHMAD A., F.D. DASCHNER et K. KÜMMERER (1999). Biodegradability of cefotiam, ciprofloxacin, meropenem, penicillin G, and sulfametoxazole and inhibition of wastewater bacteria. Arch. Environ. Contam. Toxicol, 37, 158–163.
- AMIN M.M., J.L. ZILLES, J. GREINER, S. CHARBONNEAU, L. RASKIN et E. MORGENROTH (2006). Influence of the antibiotic erythromycin on anaerobic treatment of a pharmaceutical wastewater. Environ. Sci. Technol., 40, 3971-3977.
- ANDERSON, P.D., V.J. D’ACO, P. SHANAHAN, S.C. CHAPRA, M.E. BUZBY, V.L. CUNNINGHAM, B.M. DUPLESSIE, E.P. HAYES, F.J. MASTROCCO, N.J. PARKE, J.C. RADER, J.H. SAMUELIAN et B.W. SCHWAB (2004). Screening analysis of human pharmaceutical compounds in U.S. surface waters. Environ. Sci. Technol., 38, 838-849.
- ASHTON D., M. HILTON et K.V. THOMAS (2004). Investigating the environmental transport of human pharmaceuticals to streams in the United Kingdom. Sci. Total Environ., 333, 167-184.
- BATT A.L., I.B. BRUCE et D.S. AGA (2006). Evaluating the vulnerability of surface waters to antibiotic contamination from varying wastewater treatment plant discharges. Environ. Pollut., 142, 295-302.
- BATT A.L., S. KIM et D.S. AGA (2007). Comparison of the occurrence of antibiotics in four full-scale wastewater treatment plants with varying designs and operations. Chemosphere. 68, 428–435.
- BENDZ D., N. PAXÉUS, T.R. GINN et F.J. LOGE (2005). Occurrence and fate of pharmaceutically active compounds in the environment, a case study: Höje River in Sweden. J. Hazardous Mater., 122, 195-204.
- BENOTTI M.J. et B.J. BROWNAWELL (2007). Distributions of pharmaceuticals in an urban estuary during both dry- and wet-weather conditions. Environ. Sci. Technol., 41, 5795-5802.
- BROWN K.D., J. KULIS, B. THOMSON, T. CHAPMAN et D.B. MAWHINNEY (2006). Occurrence of antibiotics in hospital, residential and dairy effluent, municipal wastewater in the Rio Grande in New Mexico. Sci. Total Environ., 366, 772-783.
- BRUCHET A., C. HOCHEREAU, C. PICARD, V. DECOTTIGNIES, J.M. RODRIGUES et M.L. JANEX-HBIBI (2005). Analysis of drugs and personal care products in French source and drinking water: the analytical challenge and example of application. Water Sci. Technol., 52(8) 53-61.
- BURSCH W., M. FUERHACKER, M. GEMINER, B. GRILLITSCH, A. JUNGBAUER, N. KREUZINGER, E. MOEST, S. SCHARF, S. SCHMID, S. SKUTAN et I. WALTER (2004). Endocrine disrupters in aquatic environment: The Austrian approach – ARCEM. Water Sci. Technol., 50 (5) 293-300.
- CAISSE NATIONALE DE L’ASSURANCE MALADIE (2007), Consommation et dépenses de médicaments en Europe, Point d’information mensuel du 19 octobre 2007, CNAMTS, Paris, France, 14 p.
- CALAMARI D., E. ZUCCATO, S. CASTIGLIONI, R. BAGANTI ET R. FANELLI (2003). Strategic survey of therapeutic drugs in the rivers Po and Lambro in Northern Italy. Environ. Sci. Technol., 37, 1241-1248.
- CAMPOS J.L., J.M. GARRIDO, R. MÉNDEZ et J.M LEMA. (2001). Effect of broad spectrum antibiotics on activity and stability of continuous nitrifying system. Appl. Biochem. Biotechnol., 95, 1-10.
- CASTIGLIONI S., R. BAGNATI, R. FANELLI, F. POLATI, D. CALAMARI et E. ZUCCATO (2006). Removal of pharmaceuticals in sewage treatment plants in Italy. Environ. Sci. Technol., 40, 357-363.
- CHANG H., J. HU et B. SHAO (2007). Occurrence of natural and synthetic glucocorticoids in sewage treatment plants and receiving river waters. Environ. Sci. Technol., 41, 3462-3468.
- CLARA M., B. STRENN, M. AUSSERLEITNER et N. KREUZINGER (2004). Comparison of selected micropollutants in the membrane bioreactor and a conventional wastewater treatment plant. Water Sci. Technol., 50, 29-36.
- COMORETTO L., et S. CHIRON (2005). Comparing pharmaceutical and pesticide loads into a small Mediterranean river. Sci. Total Environ., 349, 201-210.
- COORS A., P.D. JONES, J.P. GIESY et H.T. RATTE (2004). Assessing the elimination of estrogenic activity in advanced wastewater treatment with a reporter gene-based bioassay. Water Sci. Technol., 50, 181-188.
- COSTANZO S.D., J. MURBY et J. BATES (2005). Ecosystem response to antiboitcs entering the aquatic system. Mar. Pollut. Bull., 51, 218-223.
- EDGE T. et S. HILL (2005). Occurrence of antibiotic resistance in Escherichia coli from surface waters and fecal pollution sources near Hamilton, Ontario. Can. J. Microbiol. 51, 501-505.
- ELBAZ-POULICHET F., J.-L. SEIDEL, C. OTHONIEL (2002). Occurrence of an anthropogenic gadolinium anomaly in river and coastal waters of Southern France. Water Res., 36, 1102-1105.
- FERRARI B., N. PAXÉUS, R.L. GIUDICE, A. POLLIO et J. GARRIC (2003). Ecotoxicological impact of pharmaceuticals found in treated wastewaters: study of carbamazepine, clofibric acid, and diclofenac. Ecotoxicol. Environ. Safe., 55, 359–370.
- GAGNÉ F, C. BLAISE et C. ANDRÉ (2006). Occurrence of pharmaceutical products in a municipal effluent and toxicity to rainbow trout (Oncorhynchus mykiss) hepatocytes. Ecotoxicol. Environ. Safe., 64, 329–336.
- GLASSMEYER, S., D.W. KOLPIN, E.T. FURLONG, et M.T. FOCAZIO, (2008). Environmental presence and persistence of pharmaceuticals--An overview. Dans: AGA, D.S., ed., Fate of Pharmaceuticals in the Environment and in Water Treatment Systems, CRC Press, Taylor and Francis Books, p. 3-51.
- GODFREY E., W.W. WOESSNER et. M.J. BENOTTI (2007). Pharmaceuticals in on-site sewage effluent and ground water, Western Montana. Ground Water, 45, 263‑271.
- GÓMEZ J., R. MÉNDEZ et J.M. LEMA (1996). The effect of antibiotics on nitrification processes. Appl. Biochem. Biotechnol., 57/58, 869-876.
- GOÑI-URRIZA M., M. CAPDEPUY, C. ARPIN, N. RAYMOND, P. CAUMETTE et C. QUENTIN(2000). Impact of an urban effluent on antibiotic resistance of riverine enterobacteriaceae and Aeromonas spp.Appl. Environ. Microb., 66, 125-132.
- GÖBEL A., C.S. MCARDELL et W. GIGER (2004). Determination of macrolide and sulphonamide antibiotics in wastewater treatment. Proceedings of SETAC Europe 14th Annual Meeting, Prague, République Tchèque, 293.
- GÖBEL A., A. THOMSEN, C.S. MCARDELL, A. JOSS et W. GIGER (2005). Occurrence and sorption behaviour of sulfamindes, macrolides and trimethoprim in activated sludge treatment. Environ. Sci. Technol., 39, 3981-3989.
- GÖBEL A., C. MCARDELL, A. JOSS, H. SIEGRIST et W. GIGER (2007). Fate of sulfonamides, macrolides, and trimethoprim in different wastewater treatment technologies. Sci. Total Environ., 372, 361-371.
- HALDEN R. U. et D.H. PAULL (2005). Co-occurrence of triclocarban and triclosan in U.S. water resources, Environ. Sci. Technol., 39, 1420-1426.
- HALLING-SØRENSEN B., S.N. NIELSEN, P.F. LANZKY, F. INGERSLEV, H.C.H. LÜTZHØFT et S.E. JORGENSEN (1998). Occurrence, fate and effects of pharmaceutical substances in the environment- A review. Chemosphere, 36, 357-393.
- HARWOOD V.J., J. WHITLOCK et V. WITHINGTON (2000). Classification of antibiotic resistance patterns of indicator bacteria by discriminant analysis: use in predicting the source of fecal contamination in subtropical waters. Appl. Environ. Microb., 66: 3698-3704.
- HARTIG C., T. STORM et M. JEKEL (1999). Detection and identification of sulphonamide drugs in municipal waste water by liquid chromatography coupled with electrospray ionisation tandem mass spectrometry. J. Chromatogr. A, 854, 163-173.
- HEBERER T. (2002a). Occurrence, fate, and removal of pharmaceutical residues in the aquatic environment: a review of recent research data. Toxicol. Lett., 131, 5–17.
- HEBERER T. (2002b). Tracking persistent pharmaceutical residues from municipal sewage to drinking water. J. Hydrol., 266, 175-189.
- HIRSCH R., T. TERNES, K. HABERER, K.L. KRATZ (1999). Occurrence of antibiotics in the aquatic environment. Sci. Total Environ., 225, 109-118.
- HIRSCH R., T.A. TERNES, A. LINDART, K. HABERER et R.-D. WILKEN (2000). A sensitive method for the determination of iodine containing diagnostic agents in the aqueous matrices using LC electro spray tandem MS-detection. Fresenius J. Anal. Chem, 366, 835-841.
- HOENICKE R., D.R. OROS, J.J. ORAM et K.M. TABERSKI (2007). Adapting an ambient monitoring program to the challenge of managing pollutants in the San Francisco estuary. Environ. Res.. 105, 132-144.
- HOLM J.V., K. RÜGGE, P.L. BJERG et T.H. CHRISTENSEN (1995). Occurrence and distribution of pharmaceutical organic compounds in the groundwater down gradient of a landfill (Grindsted, Denmark). Environ. Sci. Technol. 29, 1415–1420.
- JACOBSEN B.N., D. KJERSGAARD, M. WINTHER-NIELSEN et K. GUSTAVSON (2004). Combined chemical analyses and biomonitoring at Avedoere WWTP in 2002. Water Sci. Technol., 50(5) 37-43.
- JØRGENSEN S.E. et B. HALLING-SØRENSEN (2000). Drugs in the environment, Chemosphere, 40, 691–699.
- JOHNSON A.C., A. BELFROID et A.D. DI CORCIA (2000). Steroid oestrogen inputs into activated sludge treatment works and observations on their removal from the effluent. Sci. Total Environ., 256,163-173.
- JONES O.A.H., N. VOULVOULIS et J.N. LESTER (2002). Aquatic environmental assessment of the top 25 English prescription pharmaceuticals. Water Res., 36, 5013–5022.
- JONES O.A.H., N. VOULVOULIS et J.N. LESTER (2005). Human pharmaceutical in wastewater treatment processes, Crit. Rev. Environ. Sci. Technol., 35, 401- 427.
- KAY P., P.A. BLACKWELL et A.B.A. BOXALL (2005). A lysimeter experiment to investigate the leaching of veterinary antibiotics through clay soil and comparison with field data. Environ. Pollut., 134, 333-341.
- KANDA R., G. PAUL, A. HUW, F. JAMES (2003). Pharmaceutical and personal care products in the sewage treatment works. J. Environ. Monit., 5, 823-830.
- KARTHIKEYAN K.G. et M.T. MEYER (2006). Occurrence of antibiotics in wastewater treatment facilities in Wisconsin. USA. Sci. Total Environ., 361, 196-207.
- KASPRZYK-HORDERN B, R.M. DINSDALE et A.J. GUWY (2008) The occurrence of pharmaceuticals, personal care products, endocrine disruptors and illicit drugs in surface water in South Wales, UK. Water Res., 42, 3498-3518.
- KEMPER N. (2008). Veterinary antibiotics in the aquatic and terrestrial environment. Ecol. Indicators. 8, 1-13.
- KIM Y.H. et C.R. CERNIGLIA (2005). Influence of erythromycin A on the microbial populations in aquaculture sediment microcosms. Aquat. Toxicol., 73, 230-241.
- KIM S.C. et K. CARLSON (2006). Occurrence of ionophore antibiotics in water and sediments of a mixed-landscape watershed. Water Res., 40, 2549-2560.
- KLEYWEGT, S., S-A. SMYTH, J. PARROTT, K. SCHAEFER, E. LAGACÉ, M. PAYNE, E. TOPP, A. BECK, A. MCLAUGHLIN et K. OSTAPYK (eds) (2007) Pharmaceuticals and personal care products in the Canadian environment: Research and policy directions. NWRI, Scientific Assessment Report Series, .8, 53 p.
- KLOEPFER A., R. GNIRSS, M. JEKEL et T. REEMTSMA (2004). Occurrence of benzothiazoles in municipal wastewater and their fate in biological treatment. Water Sci. Technol., 50(5) 203-208.
- KOLPIN D.W., E.T. FURLONG, M.T. MEYER, E.M. THURMAN, S.D. ZAUGG et H.T. BUXTON (2002). Pharmaceuticals, hormones, and other organic wastewater contaminants in U.S. streams, 1999-2000: A national reconnaissance. Environ. Sci. Technol., 36, 1202‑1211.
- KOIKE S., I.G. KRAPAC, H.D. OLIVER, A.C. YANNARELL, J.C. CHEE-SANFORD, R.I. AMINOV, et R.I. MACKIE (2007). Monitoring and source tracking of tetracycline resistance genes in lagoons and groundwater adjacent to swine production facilities over a 3-year period. Appl. Environ. Microb., 73, 4813-4823.
- KRUAWAL K., F. SACHER, A. WERNER, J. MÜLLER et T.P. KNEPPER (2005). Chemical water quality in Thailand and ist impact on the drinking water production in Thailand. Sci. Total Environ., 340, 57-70.
- KUHN I., A. IVERSEN, M. FINN, C. GREKO, L. BURMAN, A.R. BLANCH, X. VOLANOVA, A. MANERO, H. TAYLOR, J. CAPLIN, L. DOMINGUEZ, I. HERRERO, M. MORENO et R. MOLLBY (2005). Occurrence and relatedness of vancomycin-resistant enterococci in animals, humans and the environment in different European regions. Appl. Environ. Res., 71, 5383‑5390.
- KÜMMERER K., T. STEGER-HARTMANN et M. MEYER (1997). Biodegradability of the anti-tumour agent ifosfamide and its occurrence in hospital effluents and communal sewage. Water Res., 31, 2705-2710.
- KÜMMERER K. (2001). Drugs in the environment: emission of drugs, diagnostic aids and disinfectants into wastewater by hospitals in relation to other sources – a review. Chemosphere, 45, 957-969.
- KÜMPEL T., R. ALEXY et K. KÜMMERER (2001). What do we know about antibiotics in the environment? Dans: Pharmaceuticals in the Environment: Sources, Fate, Effects and Risks, Kümmerer K. (Éditeur), Springer, Heidelberg. Allemagne, 522 p.
- LARSSON D.G.J., C. de PEDRO et N. PAXEUS (2007). Effluent from drug manufactures contains extremely high levels of pharmaceuticals. J. Hazardous Mater., 148, 751‑755.
- LINDQVIST N., T. TUHKANEN et L. KRONBERG (2005). Occurrence of acidic pharmaceuticals in raw and treated sewages and in receiving waters. Water Res., 39, 2219–2228.
- LOOS R., J. WOLLGAST et G. HANKE (2007). Polar herbicides, pharmaceutical products, perfluorooctanesulfonate (PFOS), perfluorooctanoate (PFOA), and nonylphenol and ist carboxylates and ethoxylates in surface and tap waters around Lake Maggiore in Northern Italy, Analyt. Bioanalyt. Chem., 387, 1469‑1478.
- LORAINE G.A. et M.E. PETTIGROVE (2003). Seasonal variations in concentrations of pharmaceutical and personal care products in drinking water and reclaimed wastewater in Southern California. Environ. Sci. Technol., 40, 68‑695.
- LÖFFLER D. et T.A. TERNES (2003). Determination of acidic pharmaceuticals, antibiotics and ivermectin in river sediment using liquid chromatography–tandem mass spectrometry. J. Chromatogr. A, 1021, 133–144.
- MA M., K. RAO et Z. WANG, (2007). Occurrence of estrogenic effects in sewage and industrial wastewaters in Beijing, China, Environ. Pollut., 147, 331-336.
- MACARDELL C.S., E. MOLNAR, M.J.F. SUTER et W. GIGER (2003). Occurrence and fate of macrolide antibiotics in wastewater treatment plants and in the Glatt Valley watershed, Switzerland. Environ. Sci. Technol., 37, 5479-5486.
- MANAGAKI S., A. MURATA, H. TAKADA, B.C. TUYEN et N.H. CHIEM (2007). Distribution of macrolides, sulfonamides and trimethoprim in tropical waters: ubiquitous occurrence of veterinary antibiotics in the Mekong delta. Environ. Sci. Technol., 41, 8004-8010.
- MARTINS A.F., T.G. VASCONCELOS, D.M. HENRIQUES, C. da S. FRANK, A. KÖNIG et K. KÜMMERER (2008). Concentration of ciprofloxacin in Brazilian hospital effluent and preliminary risk assessment: A Case Study. CLEAN - Soil, Air, Water, 36, 264-269
- MARTINS DA COSTA P., P. VAZ-PIRES et F. BERNARDO (2006). Antimicrobial resistance of Enteroccus spp. Isolated in inflow, effluent and sludge from municipal seage water treatment plants. Water Res., 40, 1735-1740.
- MIAO X.S., F. BISHAY, M. CHEN et C.D. METCALFE (2004). Occurrence of antimicrobials in the final effluents of wastewater treatment plants in Canada. Environ. Sci. Technol, 38, 3533-3541
- MONS M.N., J.F.M. VERSTEEGH, S.M. SCHRAP, P.G. STOKS et T.H.M. NOIJ (2004). Pharmaceuticals in drinking water and human health, Proc. SETAC Europe 14th Annual Meeting, Prague, République Tchèque, 294.
- NAKADA N., T. TANISHIMA, H. SHINOHARA, K. KIRI et H. TAKADA (2006). Pharmaceutical chemicals and endocrine disrupters in municipal wastewater in Tokyo and their removal during activated sludge treatment. Water Res., 40, 3297‑3303.
- NAKADA N., K. KOMORI, Y. SUZUKI, C. KONISHI, I. HOUWA et H. TANAKA (2007). Occurrence of 70 pharmaceutical and personal care products in Tone River basin in Japan, Water Sci. Technol., 56(12) 133-140.
- PALMER P.M., L.R. WILSON, P. O’KEEFE, R. SHERIDAN, T. KING et C.Y. CHEN (2008) Sources of pharmaceutical pollution in the New York City watershed, Sci. Total Environ., in press.
- PAXÉUS N. (2003). Removal of selected NASIDs, gemfibrozil, carbamazepin, β-blockers, trimethoprim and triclosan in conventional wastewater treatment plants in five EU countries and their discharge to the aquatic environment. Proceedings of the 4th IWA Specialized Conference on Assessment and Control of Hazardous Substances in Water, Aachen, Allemagne.
- PENA A., D. CHMIELOVA, C.M. LINO et P. SOLICH (2007). Determination of fluoroquinolone antibiotics in surface waters from Mondego River by high performance liquid chromatography using a monolithic column. J. Sep. Sci., 30, 2924-2928
- PESCHKA M., J.P. EUBELER et T.P. KNEPPER (2006). Occurrence and fate of barbiturates in the aquatic environment. Environ. Sci. Technol., 40, 7200-7206.
- PRUDEN A., P. RUOTING, H. STORTEBOOM, K. CARLSON et J.A. FIELD (2006). Antibiotic resistance genes as emerging contaminants: Studies in Northern Colorado. Environ. Sci. Technol.,, 40, 7445-7450.
- RABIET M., A. TOGOLA, F. BRISSAUD, J.-L. SEIDEL, H. BUDZINSKI et F. ELBAZ-POULICHET (2006). Consequences of treated water recycling as regards pharmaceuticals and drugs in surface and ground waters of a medium-sized Mediterranean catchment. Environ. Sci. Technol., 40, 5282-5288.
- REEMTSMA T., S. WEISS, J. MUELLER, M. PETROVIC, S. GONZALEZ, D. BARCELO, F. VENTURA et T.P. KNEPPER (2006). Polar pollutants entry into the water cycle by municipal wastewater: An European perspective. Environ. Sci. Technol., 40, 5451-5458.
- RAPPORT DE LA CAISSE NATIONALE D’ASSURANCE MALADIE (2007). Consommation et dépenses de médicaments en Europe, Paris, France, 14 p.
- SCHNEIDER C., B. KUCH, C. HOHLSTEIN, S. GAISER et W.J. METZGER (2004). Fate of synthetic organic substances in wastewater treatment process. Proc. SETAC Europe 14th Annual Meeting, Prague, République Tchèque, 213 p.
- SCHWAB B.W., E.P. HAYES, J.M. FIORI, F.J. MASTROCCO, N.M. RODEN, D. CRAGIN, R.D. MEYERHOFF, V.J. D’ACO et P.D. ANDERSON (2005). Human pharmaceuticals in US surface waters: A human health risk assessment. Regul. Toxicol. Pharmacol., 42, 296‑312.
- ROOKLIDGE S.J. (2004). Environmental antimicrobial contamination from terraccumulation and diffuse pollution pathways. Sci. Total Environ., 325, 1-13.
- SHAW J.W., W.C. HORRACE et R.J. VOGEL (2005). The determinants of life expectancy: ana analysis of the OECD health data. Southern Eco. J., 71, 768-783.
- SIEMENS J., G. HUSCHEK, C. SIEBE et M. KAUPENJOHANN (2008). Concentrations and mobility of human pahrmaceuticals in the world’s largest wastewater irrigation system, Mexico City, Mezquital Valley. Water Res., in press.
- STEGER-HARTMANN T., K. KÜMMERER et A. HARTMANN (1997). Biological degradation of cyclophosphamide and its occurrence in sewage water. Ecotoxicol. Environ. Safe., 35, 174-179.
- STUER-LAURIDSEN F., M. BIRKVED, L.P. HANSEN, H.‑C. HOLTEN LÜTZHØFT et B. HALLING-SØRENSEN (2000). Environmental risk assessment of human pharmaceuticals in Denmark after normal therapeutic use. Chemosphere, 40, 783-793.
- STRENN B., M. CLARA, O. GANS et N. KREUZINGER (2004). Carbamazepine, diclofenac, ibuprofen and bezafibrate- investigation on the behaviour of selected pharmaceuticals during wastewater treatment. Water Sci. Technol., 50(5) 269-276.
- STUMPF M., T.A. TERNES, R.-D. WILKEN, S.V. RODRIGUES et W. BAUMANN (1999). Polar drug residues in sewage and natural waters in the state of Rio de Janeiro, Brazil, Sci. Total Environ., 225, 135-141.
- TERNES T.A. (1998). Occurrence of drugs in German sewage treatment plants and rivers, Water Res., 32, 3245-3260.
- TERNES T.A. (2001). Analytical methods for the determination of pharmaceuticals in aqueous environmental samples. Trends Analyt. Chem., 20, 419‑434.
- TERNES T.A., M. BONERZ et T. SCHMIDT (2001). Determination of neutral pharmaceuticals in wastewater and rivers by liquid chromatography–electrospray tandem mass spectrometry. J. Chromatogr. A, 938, 175-185.
- TERNES T.A., M.-L. JANEX-HABIBI, T. KNACKER, N. KREUZINGER et H. SIEGRIST (2004). Assessment of technologies for the removal of pharmaceuticals and personal care products in sewage and drinking water facilities to improve the indirect potable water reuse. Rapport final POSEIDON (EVK1-CT-2000-00047).
- THIELE-BRUHN S. (2003). Pharmaceutical antibiotic compounds in soils - a review. J. Plant Nutr. Soil Sci., 166, 145-167.
- VIENO N.M., T. TUHKANEN et L. KRONBERG (2005). Seasonal variation in the occurrence of pharmaceuticals in effluents from a sewage treatment plant and in the recipient water. Environ. Sci. Technol. 39, 8220-226.
- WATKINSON A.J., G.B. MICALIZZI, G.M. GRAHAM, J.B. BATES et S.D. COSTANZO (2007). Antibiotic-resistant Escherichia coli in wastewaters, surface waters, and oysters from an urban riverine system. Appl. Environ. Microb., 73, 5667-5670.
- WEBB S.F. (2001). A data-based perspective on the environmental risk assessment of human pharmaceuticals II-aquatic risk characterisation, Dans: Pharmaceuticals in the Environment: Sources, Fate, Effects and Risks, KÜMMERER K. (Éditeur), Springer, Heidelberg, Allemagne 522 p.
- WIEGEL S., A. AULINGER, R. BROACKMEYER, H. HARMS, J. LÖEFFLER, H. REINCKE, R. SCHMIDT, B. STACHEL, von W. TÜMPLING et A. WANCKE (2005). Pharmaceuticals in the river Elbe and its tributaries. Chemosphere, 57, 107-126.
- WITTERS H.E., V. RUYMEN, D. HEIJERICK et L. HOEBEKE (2004). Hospital waste water: source of distribution of pharmaceuticals with toxic potency to the environment? Proceedings of the SETAC Europe 14th Annual Meeting, Prague, République Tchèque, 88.
- XU W., G. ZHANG, X. LI, S. ZOU, P. LI, Z. HU et J. LI, (2007). Occurrence and elimination of antibiotics at four sewage treatment plants in the Pearl River Delta (PRD), South China. Water Res., 41, 4526 - 4534.
- YANG S. et K.H. CARLSON (2004). Solid-phase extraction-high-performance liquid chromatography-ion trap mass spectrometry for analysis of trace concentration of macrolide antibiotic in natural and wastewater matrices. J. Chromatogr. A, 1038, 141-155.
- YASOJIMA M., N. NAKADA, K. KOMORI, Y. SUZUKI, et H. TANAKA (2006). Occurrence of levofloxacin, clarithromycin and azithromycin in wastewater treatment plant in Japan. Water Sci. Technol., 53(11) 227‑233.
- ZHANG R., Y. WANG et J.D. GU (2006). Identification of environmental plasmid-bearing Vibrio species isolated from polluted and pristine marine reserves in Hong-Kong, and resistance to antibiotics and mercury. Antonie van Leeuwenhoek, 89, 307-315.
- ZHANG S., Q. ZHANG, S. DARISAW, O. EHIE et G. WANG (2007). Simultaneous quantification of polycyclic aromatic hydrocarbons (PAHs), polychlorinated biphenyls (PCBs) and pharmaceuticals and personal care products (PPCPs) in Mississipi river water, in New Orleans, Louisiana, USA. Chemosphere, 66, 1057-1069.
- ZUCCATO E., S. CASTIGLIONI et R. FANELLI (2005). Identification of the pharmaceuticals for human use contaminating the Italian aquatic environment. J. Hazardous Mater., 122, 205-209.
- ZWIENER C. et F.H. FRIMMEL (2000). Oxidative treatment of pharmaceuticals in water. Water Res., 34, 1881‑1885.
- ZWIENER C., T.J. GREMM et F.H. FRIMMEL (2001). Pharmaceutical residues in the aquatic environment and their significance for drinking water production. Dans: Pharmaceuticals in the Environment: Sources, Fate, Effects and Risks, KÜMMERER K. (Éditeur), Springer, Heidelberg, Allemagne, 522 p.